Medicare Enrolled
Dr. Steve Perkins, MD
Hematology & Oncology · Irving, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perkins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perkins?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perkins
Dr. Steve Perkins is a hematology & oncology specialist in Irving, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perkins performed 36,170 Medicare services across 2,736 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perkins received a total of $2,458 from 29 pharmaceutical and/or device companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perkins is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in TX
$2,458 industry payments
Medicare Practice Summary
Medicare Utilization ↗36,170
Medicare services
Top 26% in TX for hematology & oncology
2,736
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,808 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 16,900 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
5,400 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 2,280 | $18 | $65 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,524 | $10 | $64 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,391 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,378 | $8 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,029 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
804 | $66 | $250 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
720 | $6 | $31 |
| Anti-nausea injection (Aloxi/palonosetron) | 670 | $1 | $114 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
478 | $42 | $150 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
327 | $9 | $56 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
253 | $103 | $707 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
238 | $13 | $60 |
| Iron level test | 233 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
231 | $9 | $35 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
208 | $17 | $60 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
182 | $23 | $157 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
167 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
167 | $6 | $34 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
150 | $7 | $29 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 133 | $20 | $128 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
122 | $2 | $300 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
98 | $6 | $431 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
91 | $11 | $96 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
81 | $51 | $344 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
75 | $19 | $99 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $93 | $368 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
73 | $51 | $313 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
71 | $1 | $7 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
69 | $4 | $25 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 64 | $89 | $657 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
56 | $1,173 | $4,802 |
| PSA test (prostate cancer screening) | 53 | $18 | $94 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
49 | $12 | $108 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
48 | $35 | $143 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $24 | $145 |
| New patient office visit, complex (60-74 min) | 40 | $171 | $709 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $16 | $100 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
37 | $23 | $161 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
33 | $1 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $121 | $565 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
17 | $4 | $33 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
16 | $5 | $26 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $78 | $372 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
15 | $34 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
74.2% medium
24.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,458
Total received (2018-2024)
Avg $351/year across 7 years
Bottom 44% in TX for hematology & oncology
29
Companies
60
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Other
Charitable contributions, space rental, and other categories
$1,199 (48.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$872 (35.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$387 (15.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,423
2023
$54
2022
$145
2021
$383
2020
$14
2019
$117
2018
$322
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,230
Regeneron Healthcare Solutions, Inc.
$142
E.R. Squibb & Sons, L.L.C.
$134
Pharmacyclics LLC, An AbbVie Company
$122
Myriad Genetic Laboratories, Inc.
$122
Lilly USA, LLC
$100
Celgene Corporation
$80
Apellis Pharmaceuticals, Inc.
$68
Amgen Inc.
$44
BOSTON SCIENTIFIC CORPORATION
$40
AstraZeneca Pharmaceuticals LP
$39
Merck Sharp & Dohme Corporation
$35
Janssen Biotech, Inc.
$29
Myovant Sciences Inc.
$26
Ipsen Biopharmaceuticals, Inc
$25
PFIZER INC.
$25
Merck Sharp & Dohme LLC
$23
Seattle Genetics, Inc.
$22
SANOFI-AVENTIS U.S. LLC
$20
AbbVie, Inc.
$19
ABBVIE INC.
$18
Karyopharm Therapeutics Inc.
$16
Verastem, Inc.
$14
Seagen Inc.
$13
Daiichi Sankyo Inc.
$13
PharmaEssentia USA Corporation
$12
Gilead Sciences, Inc.
$12
Janssen Pharmaceuticals, Inc
$11
EMD Serono, Inc.
$5
Top 3 companies account for 61.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · BESREMI · BOSULIF · Bavencio · CYRAMZA · Copiktra · DARZALEX · Empaveli · EndoPredict · Enhertu · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · Nplate · OPDIVO · ORGOVYX · Pomalyst · REBLOZYL · Revlimid · SOMATULINE DEPOT · TACTRA · VENCLEXTA · Venclexta · XARELTO · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Payments are distributed across multiple categories with no single dominant type.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
154
Per 100K population
5.9
County median income
$74,149
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER AT IRVING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Perkins is a mixed practice specialist, with above-average Medicare volume (top 26% in TX), with mixed engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Perkins experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Perkins performed 16,900 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perkins receive payments from pharmaceutical companies?
Yes. Dr. Perkins received a total of $2,458 from 29 companies across 60 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perkins's costs compare to other hematology & oncology specialists in Irving?
Dr. Perkins's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perkins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Irving
Browse hematology & oncology specialists in Irving ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology